We get this one a bunch; Up to Date is pretty awesome.

Public data + our data shows only ~1/2 of clinical questions can be answered by Up to Date (or references like them).

Those online compendia employ a small team of credible authors + have massive scale, so they focus on the mainstream questions.

Our custom solution is designed around the long tail of emerging or complex questions.

For example, if you want to know about dexamethasone 4mg for early stage COVID, Up to Date will have it. But if you want to know about dexamethasone 20 mg, you’re faced with doing this literature search on PubMed (which = 2 hours + 4 journals) .

We get this question a lot, and really appreciate you surfacing it here. We made this into a FAQ for anyone that prefers to visualize it: https://www.inpharmd.com/faq

Maybe this is how any startup takes on any large incumbent? IDK. We love your collective wisdom, we learn a ton from you all.